Google Alert - hepatitis c

[Guest guest]

News

9 new results for hepatitis c

Hep C Drug Updates: Vertex and AnadysTheStreet.comBy Adam Feuerstein 10/13/11 - 11:01 AM EDT BOSTON (TheStreet) -- Vertex Pharmaceuticals(VRTX) shares are rebounding Thursday on speculation that prescription growth of its hepatitis C drug Incivek may not be flattening as much as previously feared. ...See all stories on this topic »

Hepatitis C Damage Awards Against Teva, Baxter Continue to Pile UpAboutLawsuits.comTeva Pharmaceuticals and Baxter International have been hit with a massive punitive damages award for a third time as a result of their role in causing a hepatitis C outbreak that occurred after two Las Vegas endoscopy clinics reused oversized vials of ...See all stories on this topic »

Anadys gets a boost from positive PhIIb hep C studyFierceBiotechShares of San Diego-based Anadys ($ANDS) got a bump this morning on the news that its interim data from a Phase IIb study of its hepatitis C drug setrobuvir looks positive, helping to position the developer as it angles for a place at the table for ...See all stories on this topic »

Hepatitis C Medication Adherence Is an Important Challenge, Study ShowsAIDSmeds.com HIV/AIDS Treatment NewsIdentifying and overcoming barriers to hepatitis C medication adherence is an essential component to treatment strategies, according to study results published online by ls of Internal Medicine. Patients being treated for chronic hepatitis C become ...See all stories on this topic »

From Needle Stick to Cure for HepatitisNew York Times (blog) Dieterich examines a patient, Graham, 56, who has been free of hepatitis C for five years. As doctors-in-training in the early 1990s, my friends and I became obsessed with the question of what we would do if we were pricked with an ...See all stories on this topic »

New York Times (blog)

Inovio, VGX ink hep B and C vaccine dealFierceVaccinesBlue Bell, PA-based Inovio Pharmaceuticals and VGX International will collaborate on the development of Inovio's synthetic vaccines for hepatitis B and hepatitis C. Financial details of the deal were not disclosed. Inovio's SynCon vaccine technology ...See all stories on this topic »

Janssen's Incivo for hep C launched in UKPharma TimesJanssen has launched Incivo (telaprevir), a new treatment for patients with genotype-1 chronic hepatitis C (hep C), in the UK. It is estimated that 216000-466000 people in the UK are chronically infected with hep C, of which only 80000 have been ...See all stories on this topic »

Hepatitis C verdict misplaces blameLas Vegas SunWhat a shame that the jurors in the recent hepatitis C outbreak case awarded $162.5 million in punitive damages to the three people infected. The actions of today's jurors to hand out ridiculous amounts in these cases does nothing but drive up the ...See all stories on this topic »

UC San Diego School of Medicine Launches Hepatitis C Clinical TrialsUCSD Medical CenterA collaborative partnership between the UC San Diego Liver Center and Antiviral Research Center (AVRC) has resulted in 19 clinical trials for hepatitis C virus (HCV), focused on developing more effective and well-tolerated HCV treatments. ...See all stories on this topic »

- more news

http://health.dir./group/ /links/025___HCV_DAILY_NEWS_RESOURCES_001268599268/